D. Vodák

发表

Sample-Index Misassignment Impacts Tumour Exome Sequencing

E. Hovig, H. Holte, O. Myklebost, 2018, Scientific Reports.

A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing

Michael C. Heinold, David T. W. Jones, Timothy A Beck, 2015, Nature Communications.

Performance comparison of four exome capture systems for deep sequencing

Eivind Hovig, Mohammed-Amin Madoui, Ola Myklebost, 2014, BMC Genomics.

Potentially pathogenic germline CHEK2 c.319+2T>A among multiple early-onset cancer families

P. Møller, E. Hovig, D. Vodák, 2017, Familial Cancer.

Glucocorticoid receptor and Klf4 co-regulate anti-inflammatory genes in keratinocytes

I. Mills, D. Vodák, L. Sevilla, 2015, Molecular and Cellular Endocrinology.

GSuite HyperBrowser: integrative analysis of dataset collections across the genome and epigenome

Johannes Andreas Akse, G. K. Sandve, L. Holden, 2016 .

Patterns of genomic evolution in advanced melanoma

P. Lønning, E. Hovig, O. Myklebost, 2018, Nature Communications.

Transcriptomic Profiling of Tumor Aggressiveness in Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms

E. Hovig, D. Vodák, I. Gladhaug, 2016, Pancreas.

High number of kinome‐mutations in non‐small cell lung cancer is associated with reduced immune response and poor relapse‐free survival

E. Hovig, O. Myklebost, D. Vodák, 2017, International journal of cancer.

Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy

T. Aas, S. Geisler, P. Lønning, 2022, Genome medicine.

Mutational analysis and protein profiling predict drug sensitivity in multiple myeloma cell lines

E. Hovig, D. Vodák, S. Nakken, 2022, Frontiers in Oncology.

Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy

T. Aas, S. Geisler, P. Lønning, 2022, Genome medicine.

Glycosylation is an Androgen-Regulated Process Essential for Prostate Cancer Cell Viability☆

I. Mills, L. Harries, D. Vodák, 2016, EBioMedicine.

The androgen receptor controls expression of the cancer-associated sTn antigen and cell adhesion through induction of ST6GalNAc1 in prostate cancer

I. Mills, Yan Zhou, L. Harries, 2015, Oncotarget.

Use of liquid biopsies to monitor disease progression in a sarcoma patient: a case report

E. Hovig, O. Myklebost, D. Vodák, 2017, BMC Cancer.

BRAF V600E mutation in early-stage multiple myeloma: good response to broad acting drugs and no relation to prognosis

E. Hovig, O. Myklebost, D. Vodák, 2015, Blood Cancer Journal.

Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series.

M. Lawrence, J. Myklebust, E. Smeland, 2020, Blood advances.

Unscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion, recurrent rearrangements and frequent novel TP53 aberrations

P. Campbell, R. Lothe, O. Myklebost, 2015, Oncotarget.

A Comprehensive Assessment of Somatic Mutation Calling in Cancer Genomes

Roland Eils, Pablo H. Hennings-Yeomans, Paul T. Spellman, 2014, bioRxiv.

Results of multigene panel testing in familial cancer cases without genetic cause demonstrated by single gene testing

P. Møller, E. Hovig, D. Vodák, 2019, Scientific Reports.

Identification of genetic variants for clinical management of familial colorectal tumors

P. Møller, E. Hovig, D. Vodák, 2018, BMC Medical Genetics.

TP53 Mutation Spectrum in Smokers and Never Smoking Lung Cancer Patients

A. Børresen-Dale, E. Hovig, O. Myklebost, 2016, Front. Genet..

Androgen-dependent alternative mRNA isoform expression in prostate cancer cells

D. Vodák, N. Barbosa-Morais, P. Rajan, 2018, F1000Research.

GSuite HyperBrowser: integrative analysis of dataset collections across the genome and epigenome

Finn Drabløs, Abdulrahman Azab, Diana Domanska, 2016, bioRxiv.

Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer.

Stefan J. Barfeld, M. Nykter, P. Nelson, 2017, Cell reports.

Personal Cancer Genome Reporter: variant interpretation report for precision oncology

Eivind Hovig, Sigve Nakken, Ola Myklebost, 2017, bioRxiv.

Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma - Five-Year Follow Up of a Phase I/IIa Trial

E. Hovig, D. Vodák, S. Nakken, 2021, Frontiers in Immunology.

Genetic variants of prospectively demonstrated phenocopies in BRCA1/2 kindreds

P. Møller, E. Hovig, D. Vodák, 2018, Hereditary Cancer in Clinical Practice.

A national precision cancer medicine implementation initiative for Norway

Tonje G. Lien, P. Lønning, R. Lothe, 2022, Nature Medicine.

Genetic variants of prospectively demonstrated phenocopies in BRCA1/2 kindreds

P. Møller, E. Hovig, D. Vodák, 2018, Hereditary cancer in clinical practice.

Use of liquid biopsies to monitor disease progression in a sarcoma patient: a case report

E. Hovig, O. Myklebost, D. Vodák, 2017, BMC Cancer.

Androgen-dependent alternative mRNA isoform expression in prostate cancer cells [version 1; peer review: 3 approved]

D. Vodák, N. Barbosa-Morais, P. Rajan, 2021 .

Sample-Index Misassignment Impacts Tumor Exome Sequencing

E. Hovig, H. Holte, O. Myklebost, 2017, bioRxiv.

Glucocorticoid receptor and Klf4 co-regulate anti-inflammatory genes in keratinocytes

I. Mills, D. Vodák, L. Sevilla, 2015, Molecular and Cellular Endocrinology.

Patterns of genomic evolution in advanced melanoma

P. Lønning, E. Hovig, O. Myklebost, 2018, Nature Communications.